{"id":"https://openalex.org/W2038856808","doi":"https://doi.org/10.1128/aac.01620-13","title":"Pharmacological Properties of NAI-603, a Well-Tolerated Semisynthetic Derivative of Ramoplanin","display_name":"Pharmacological Properties of NAI-603, a Well-Tolerated Semisynthetic Derivative of Ramoplanin","publication_year":2014,"publication_date":"2014-01-14","ids":{"openalex":"https://openalex.org/W2038856808","doi":"https://doi.org/10.1128/aac.01620-13","mag":"2038856808","pmid":"https://pubmed.ncbi.nlm.nih.gov/24419352","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4023767"},"language":"en","primary_location":{"id":"doi:10.1128/aac.01620-13","doi":"https://doi.org/10.1128/aac.01620-13","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.01620-13","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4023767","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055617109","display_name":"Daniela Leite Jabes","orcid":"https://orcid.org/0000-0001-7297-0784","observed_orcids":["https://orcid.org/0000-0001-7297-0784"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniela Jabes","raw_affiliation_strings":["NAICONS, Milan, Italy","Vicuron Pharmaceuticals, Gerenzano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NAICONS, Milan, Italy","institution_ids":[]},{"raw_affiliation_string":"Vicuron Pharmaceuticals, Gerenzano, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090133195","display_name":"Cristina Brunati","orcid":"https://orcid.org/0009-0007-4791-3455","observed_orcids":["https://orcid.org/0009-0007-4791-3455"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cristina Brunati","raw_affiliation_strings":["NAICONS, Milan, Italy","Vicuron Pharmaceuticals, Gerenzano, Italy","aNAICONS, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NAICONS, Milan, Italy","institution_ids":[]},{"raw_affiliation_string":"Vicuron Pharmaceuticals, Gerenzano, Italy","institution_ids":[]},{"raw_affiliation_string":"aNAICONS, Milan, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113811562","display_name":"Gianpaolo Candiani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"GianPaolo Candiani","raw_affiliation_strings":["Vicuron Pharmaceuticals, Gerenzano, Italy","bVicuron Pharmaceuticals, Gerenzano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vicuron Pharmaceuticals, Gerenzano, Italy","institution_ids":[]},{"raw_affiliation_string":"bVicuron Pharmaceuticals, Gerenzano, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009690479","display_name":"Simona Riva","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Simona Riva","raw_affiliation_strings":["Vicuron Pharmaceuticals, Gerenzano, Italy","bVicuron Pharmaceuticals, Gerenzano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vicuron Pharmaceuticals, Gerenzano, Italy","institution_ids":[]},{"raw_affiliation_string":"bVicuron Pharmaceuticals, Gerenzano, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021575939","display_name":"Gabriella Roman\u00f2","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gabriella Roman\u00f3","raw_affiliation_strings":["Vicuron Pharmaceuticals, Gerenzano, Italy","bVicuron Pharmaceuticals, Gerenzano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vicuron Pharmaceuticals, Gerenzano, Italy","institution_ids":[]},{"raw_affiliation_string":"bVicuron Pharmaceuticals, Gerenzano, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072331809","display_name":"Sonia Ilaria Maffioli","orcid":"https://orcid.org/0000-0001-5489-5995","observed_orcids":["https://orcid.org/0000-0001-5489-5995"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sonia Maffioli","raw_affiliation_strings":["NAICONS, Milan, Italy","Vicuron Pharmaceuticals, Gerenzano, Italy","aNAICONS, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NAICONS, Milan, Italy","institution_ids":[]},{"raw_affiliation_string":"Vicuron Pharmaceuticals, Gerenzano, Italy","institution_ids":[]},{"raw_affiliation_string":"aNAICONS, Milan, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110072728","display_name":"Rosaria Rossi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rosaria Rossi","raw_affiliation_strings":["Vicuron Pharmaceuticals, Gerenzano, Italy","bVicuron Pharmaceuticals, Gerenzano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vicuron Pharmaceuticals, Gerenzano, Italy","institution_ids":[]},{"raw_affiliation_string":"bVicuron Pharmaceuticals, Gerenzano, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052556912","display_name":"Matteo Simone","orcid":"https://orcid.org/0009-0006-6025-6261","observed_orcids":["https://orcid.org/0009-0006-6025-6261"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matteo Simone","raw_affiliation_strings":["NAICONS, Milan, Italy","aNAICONS, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NAICONS, Milan, Italy","institution_ids":[]},{"raw_affiliation_string":"aNAICONS, Milan, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062404271","display_name":"Eleonora Gaspari","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eleonora Gaspari","raw_affiliation_strings":["NAICONS, Milan, Italy","aNAICONS, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NAICONS, Milan, Italy","institution_ids":[]},{"raw_affiliation_string":"aNAICONS, Milan, Italy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069595808","display_name":"Stefano Donadio","orcid":"https://orcid.org/0000-0002-2121-8979","observed_orcids":["https://orcid.org/0000-0002-2121-8979"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stefano Donadio","raw_affiliation_strings":["NAICONS, Milan, Italy","Vicuron Pharmaceuticals, Gerenzano, Italy","aNAICONS, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NAICONS, Milan, Italy","institution_ids":[]},{"raw_affiliation_string":"Vicuron Pharmaceuticals, Gerenzano, Italy","institution_ids":[]},{"raw_affiliation_string":"aNAICONS, Milan, Italy","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.3765,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.80944427,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"58","issue":"4","first_page":"1922","last_page":"1929"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.5849999785423279,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.5849999785423279,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11103","display_name":"Antimicrobial Peptides and Activities","score":0.1914999932050705,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12526","display_name":"Antimicrobial agents and applications","score":0.10109999775886536,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/macrolide-antibiotics","display_name":"macrolide antibiotics","score":0.652999997138977},{"id":"https://openalex.org/keywords/gram-positive-bacterial-infections","display_name":"Gram-positive bacterial infections","score":0.6110000014305115},{"id":"https://openalex.org/keywords/methicillin-resistant-staphylococcus-aureus","display_name":"methicillin-resistant Staphylococcus aureus","score":0.9070000052452087},{"id":"https://openalex.org/keywords/vancomycin-resistant-enterococci","display_name":"vancomycin-resistant enterococci","score":0.9919999837875366},{"id":"https://openalex.org/keywords/bactericidal-activity","display_name":"bactericidal activity","score":0.6470000147819519},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.703000009059906},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.5690000057220459},{"id":"https://openalex.org/keywords/antibiotic-tolerability","display_name":"antibiotic tolerability","score":0.46000000834465027},{"id":"https://openalex.org/keywords/vancomycin-resistance","display_name":"vancomycin resistance","score":0.5170000195503235},{"id":"https://openalex.org/keywords/linezolid","display_name":"linezolid","score":0.6729999780654907},{"id":"https://openalex.org/keywords/teicoplanin","display_name":"teicoplanin","score":0.9850000143051147},{"id":"https://openalex.org/keywords/vancomycin","display_name":"vancomycin","score":0.6650000214576721},{"id":"https://openalex.org/keywords/vancomycin-resistance-genes","display_name":"vancomycin resistance genes","score":0.31700000166893005}],"concepts":[{"id":"https://openalex.org/C2776703206","wikidata":"https://www.wikidata.org/wiki/Q2731762","display_name":"Teicoplanin","level":5,"score":0.611144483089447},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.5788555145263672},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.5677051544189453},{"id":"https://openalex.org/C2778980435","wikidata":"https://www.wikidata.org/wiki/Q424027","display_name":"Vancomycin","level":4,"score":0.4931780695915222},{"id":"https://openalex.org/C2781414143","wikidata":"https://www.wikidata.org/wiki/Q411377","display_name":"Linezolid","level":5,"score":0.4889291822910309},{"id":"https://openalex.org/C2777052132","wikidata":"https://www.wikidata.org/wiki/Q595158","display_name":"Methicillin-resistant Staphylococcus aureus","level":4,"score":0.4869057238101959},{"id":"https://openalex.org/C3019249092","wikidata":"https://www.wikidata.org/wiki/Q274493","display_name":"Antibacterial agent","level":3,"score":0.4802532494068146},{"id":"https://openalex.org/C176947019","wikidata":"https://www.wikidata.org/wiki/Q597889","display_name":"Minimum inhibitory concentration","level":3,"score":0.4762982428073883},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42136162519454956},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.39997047185897827},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3708510994911194},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.36050093173980713},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24028614163398743},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.16364803910255432},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069349","descriptor_name":"Linezolid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000081","descriptor_name":"Acetamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000081","descriptor_name":"Acetamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008813","descriptor_name":"Mice, Inbred ICR","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013203","descriptor_name":"Staphylococcal Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014640","descriptor_name":"Vancomycin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014640","descriptor_name":"Vancomycin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016983","descriptor_name":"Enterococcus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017334","descriptor_name":"Teicoplanin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017334","descriptor_name":"Teicoplanin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D023303","descriptor_name":"Oxazolidinones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D023303","descriptor_name":"Oxazolidinones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D047630","descriptor_name":"Depsipeptides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055624","descriptor_name":"Methicillin-Resistant Staphylococcus aureus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1128/aac.01620-13","doi":"https://doi.org/10.1128/aac.01620-13","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.01620-13","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4023767","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4023767","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:24419352","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24419352","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4023767","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4023767","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W611976593","https://openalex.org/W644335729","https://openalex.org/W1975218610","https://openalex.org/W1977377333","https://openalex.org/W1986363882","https://openalex.org/W1987495901","https://openalex.org/W2005721855","https://openalex.org/W2006259925","https://openalex.org/W2032846418","https://openalex.org/W2045153874","https://openalex.org/W2050751459","https://openalex.org/W2054781550","https://openalex.org/W2063447937","https://openalex.org/W2073442625","https://openalex.org/W2099952421","https://openalex.org/W2111826373","https://openalex.org/W2115024117","https://openalex.org/W2125529362","https://openalex.org/W2127059574","https://openalex.org/W2141011536","https://openalex.org/W2144126572","https://openalex.org/W2144347018","https://openalex.org/W2150855562","https://openalex.org/W2161963100","https://openalex.org/W2164412101","https://openalex.org/W2166329107","https://openalex.org/W2167789057","https://openalex.org/W2169092475","https://openalex.org/W2169673522","https://openalex.org/W2197881166","https://openalex.org/W2314609355","https://openalex.org/W2320678696","https://openalex.org/W2398208509","https://openalex.org/W2423024596","https://openalex.org/W2743041357","https://openalex.org/W4230030027","https://openalex.org/W4301462575"],"related_works":["https://openalex.org/W2401889357","https://openalex.org/W2049730653","https://openalex.org/W2006259925","https://openalex.org/W2418702207","https://openalex.org/W2142330123","https://openalex.org/W2161963100","https://openalex.org/W2007344999","https://openalex.org/W1971136139","https://openalex.org/W2121047062","https://openalex.org/W2125492907"],"abstract_inverted_index":{"NAI-603":[0,19,65,132,166,226,248],"is":[1,20],"a":[2,16,115,204],"ramoplanin":[3,228],"derivative":[4],"designed":[5],"to":[6,34,46,51,87,91,169,174,206],"overcome":[7],"the":[8,12,95,124,163,188,212,241,262],"tolerability":[9,266],"issues":[10],"of":[11,57,80,129,139,178,225,258,264],"parent":[13],"drug":[14],"as":[15],"systemic":[17,116],"agent.":[18],"highly":[21],"active":[22],"against":[23],"aerobic":[24],"and":[25,63,93,145,227,236],"anaerobic":[26],"Gram-positive":[27],"bacteria,":[28],"with":[29,69,159,240,261],"MICs":[30,37],"ranging":[31],"from":[32],"0.008":[33],"8":[35],"\u03bcg/ml.":[36],"were":[38,167],"not":[39],"significantly":[40],"affected":[41],"by":[42,48,55,119,194],"pH":[43],"(range,":[44],"6":[45],"8),":[47],"inoculum":[49],"up":[50],"10(8)":[52],"CFU/ml,":[53],"or":[54,151],"addition":[56],"50%":[58,125],"human":[59],"serum.":[60],"Against":[61],"staphylococci":[62],"enterococci,":[64],"was":[66,83,133,183],"rapidly":[67],"bactericidal,":[68],"minimum":[70],"bactericidal":[71,181],"concentration":[72,243],"(MBC)/MIC":[73],"ratios":[74],"never":[75],"exceeding":[76],"4.":[77],"The":[78,180,221,254],"frequency":[79],"spontaneous":[81],"resistance":[82],"low":[84],"at":[85,100,104,107,198,229],"2\u00d7":[86],"4\u00d7":[88],"MIC":[89],"(\u22641\u00d710(-6)":[90],"\u22641\u00d710(-8))":[92],"below":[94],"detection":[96],"limit":[97],"(about":[98],"\u22641\u00d710(-9))":[99],"8\u00d7MIC.":[101],"Serial":[102],"subcultures":[103],"0.5\u00d7MIC":[105],"yielded":[106],"most":[108],"an":[109],"8-fold":[110],"increase":[111],"in":[112,185,187,208,211],"MICs.":[113],"In":[114,155],"infection":[117],"induced":[118,193,202],"methicillin-resistant":[120],"Staphylococcus":[121],"aureus":[122],"(MRSA),":[123],"effective":[126],"dose":[127],"(ED50)":[128],"intravenous":[130],"(i.v.)":[131],"0.4":[134],"mg/kg,":[135],"lower":[136],"than":[137,218],"that":[138],"oral":[140],"(p.o.)":[141],"linezolid":[142],"(1.4":[143,149],"mg/kg)":[144,150],"subcutaneous":[146],"(s.c.)":[147],"teicoplanin":[148],"vancomycin":[152],"(0.6":[153],"mg/kg).":[154],"neutropenic":[156],"mice":[157],"infected":[158],"vancomycin-resistant":[160],"enterococci":[161],"(VRE),":[162],"ED50s":[164],"for":[165,216,247],"1.1":[168],"1.6":[170],"mg/kg":[171,176,200,231],"i.v.,":[172,201],"compared":[173],"0.5":[175],"i.v.":[177],"ramoplanin.":[179],"activity":[182],"confirmed":[184],"vivo":[186],"rat":[189],"granuloma":[190],"pouch":[191],"model":[192],"MRSA,":[195],"where":[196],"NAI-603,":[197,259],"40":[199],"about":[203],"2-":[205],"3-log10-reduction":[207],"viable":[209],"bacteria":[210],"exudates,":[213],"which":[214],"persisted":[215],"more":[217],"72":[219],"h.":[220],"pharmacokinetic":[222],"(PK)":[223],"profiles":[224],"20":[230],"show":[232],"similar":[233],"half-lives":[234],"(3.27":[235],"3.80":[237],"h,":[238],"respectively)":[239],"maximum":[242],"(Cmax)":[244],"markedly":[245],"higher":[246],"(207":[249],"\u03bcg/ml":[250],"versus":[251],"79":[252],"\u03bcg/ml).":[253],"favorable":[255],"pharmacological":[256],"profile":[257],"coupled":[260],"absence":[263],"local":[265],"issues,":[267],"supports":[268],"further":[269],"investigation.":[270]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}